【24h】

Molecular breast imaging: use of a dual-head dedicated gamma camera to detect small breast tumors.

机译:分子乳腺成像:使用双头专用伽玛照相机检测小乳腺​​肿瘤。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: Molecular breast imaging with a single-head cadmium zinc telluride (CZT) gamma camera has previously been shown to have good sensitivity for the detection of small lesions. To further improve sensitivity, we developed a dual-head molecular breast imaging system using two CZT detectors to simultaneously acquire opposing breast views and reduce lesion-to-detector distance. We determined the incremental gain in sensitivity of molecular breast imaging with dual detectors. SUBJECTS AND METHODS: Patients with BI-RADS category 4 or 5 lesions < 2 cm that were identified on mammography or sonography and scheduled for biopsy underwent molecular breast imaging as follows: After injection of 740 MBq of technetium-99m ((99m)Tc) sestamibi, 10-minute craniocaudal and mediolateral oblique views of each breast were acquired. Blinded reviews were performed using images from both detectors 1 and 2 and images from detector 1 only (simulating a single-head system). Lesions were scored on a scale of 1-5; 2 or higher was considered positive. RESULTS: Of the 150 patients in the study, 128 cancers were confirmed in 88 patients. Averaging the results from the three blinded readers, the sensitivity of dual-head molecular breast imaging was 90% (115/128), whereas the sensitivity from review of only single-head molecular breast imaging was 80% (102/128). The sensitivity for the detection of cancers < or = 10 mm in diameter was 82% (50/61) for dual-head molecular breast imaging and 68% (41/61) for single-head molecular breast imaging. On average, 13 additional cancers were seen on dual-head images and the tumor uptake score increased by 1 or more in 60% of the identified tumors. CONCLUSION: Gains in sensitivity with the dual-head system molecular breast imaging are partially due to increased confidence in lesion detection. Molecular breast imaging can reliably detect breast lesions < 2 cm and dual-head molecular breast imaging can significantly increase sensitivity for subcentimeter lesions.
机译:目的:单头碲化镉锌(CZT)伽马相机进行的分子乳腺成像已被证明对检测小病变具有良好的灵敏度。为了进一步提高灵敏度,我们开发了使用两个CZT检测器的双头分子乳房成像系统,以同时获取相对的乳房影像并减少病变到检测器的距离。我们用双探测器确定了分子乳腺成像灵敏度的增量增益。研究对象和方法:经乳房X线检查或超声检查确定并计划进行活检的BI-RADS 4或5类<2 cm病灶的患者进行了分子乳腺成像,如下所示:注射740 MBq的99 99m((99m)Tc)获得了每只乳房的sestamibi,10分钟的颅尾和中外侧斜视图。使用来自检测器1和2的图像和仅来自检测器1的图像(模拟单头系统)进行盲检查。病变评分为1-5分; 2或更高被认为是阳性。结果:在研究的150名患者中,有88名患者确诊了128种癌症。平均三个盲人读者的结果,双头分子乳腺成像的敏感性为90%(115/128),而仅单头分子乳腺成像的敏感性为80%(102/128)。对于双头分子乳腺成像,检测直径≤10 mm的癌症的灵敏度为82%(50/61),对单头分子乳腺成像检测为68%(41/61)。平均而言,在双头图像上还可以看到另外13种癌症,并且在60%的已识别肿瘤中,肿瘤的摄取分数提高了1或更多。结论:双头系统分子乳腺成像的灵敏度提高部分归因于对病变检测的信心增加。分子乳腺成像可以可靠地检测2 cm以下的乳腺病变,而双头分子乳腺成像可以显着提高对厘米以下病变的敏感性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号